| A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis VA Lennon, DM Wingerchuk, TJ Kryzer, SJ Pittock, CF Lucchinetti, ... The Lancet 364 (9451), 2106-2112, 2004 | 3843 | 2004 |
| Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders DK Sato, D Callegaro, MA Lana-Peixoto, PJ Waters, FMH Jorge, ... Neurology 82 (6), 474-481, 2014 | 900 | 2014 |
| Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre T Takahashi, K Fujihara, I Nakashima, T Misu, I Miyazawa, M Nakamura, ... Brain 130 (5), 1235-1243, 2007 | 761 | 2007 |
| Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis T Misu, K Fujihara, A Kakita, H Konno, M Nakamura, S Watanabe, ... Brain 130 (5), 1224-1234, 2007 | 719 | 2007 |
| Eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder SJ Pittock, A Berthele, K Fujihara, HJ Kim, M Levy, J Palace, I Nakashima, ... New England Journal of Medicine 381 (7), 614-625, 2019 | 663 | 2019 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 621 | 2015 |
| Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan J Kitley, MI Leite, I Nakashima, P Waters, B McNeillis, R Brown, Y Takai, ... Brain 135 (6), 1834-1849, 2012 | 472 | 2012 |
| Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica T Misu, K Fujihara, I Nakashima, S Sato, Y Itoyama Neurology 65 (9), 1479-1482, 2005 | 411 | 2005 |
| MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy R Ogawa, I Nakashima, T Takahashi, K Kaneko, T Akaishi, Y Takai, ... Neurology: Neuroimmunology & Neuroinflammation 4 (2), e322, 2017 | 394 | 2017 |
| MOG cell-based assay detects non-MS patients with inflammatory neurologic disease P Waters, M Woodhall, KC O'Connor, M Reindl, B Lang, DK Sato, ... Neuroimmunology & Neuroinflammation 2 (3), e89, 2015 | 386 | 2015 |
| Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica S Watanabe, I Nakashima, T Misu, I Miyazawa, Y Shiga, K Füjihara, ... Multiple Sclerosis Journal 13 (1), 128-132, 2007 | 336 | 2007 |
| Treatment of neuromyelitis optica: review and recommendations DJ Kimbrough, K Fujihara, A Jacob, MA Lana-Peixoto, MI Leite, M Levy, ... Multiple sclerosis and related disorders 1 (4), 180-187, 2012 | 327 | 2012 |
| Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide JY Hor, N Asgari, I Nakashima, SA Broadley, MI Leite, N Kissani, A Jacob, ... Frontiers in neurology 11, 501, 2020 | 299 | 2020 |
| Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG I Nakashima, K Fujihara, I Miyazawa, T Misu, K Narikawa, M Nakamura, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (9), 1073-1075, 2006 | 285 | 2006 |
| Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial M Tahara, T Oeda, K Okada, T Kiriyama, K Ochi, H Maruyama, H Fukaura, ... The Lancet Neurology 19 (4), 298-306, 2020 | 278 | 2020 |
| Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica T Misu, R Höftberger, K Fujihara, I Wimmer, Y Takai, S Nishiyama, ... Acta neuropathologica 125, 815-827, 2013 | 247 | 2013 |
| Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients MI Leite, E Coutinho, M Lana-Peixoto, S Apostolos, P Waters, D Sato, ... Neurology 78 (20), 1601-1607, 2012 | 240 | 2012 |
| Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders A Jacob, A McKeon, I Nakashima, DK Sato, L Elsone, K Fujihara, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (8), 922-930, 2013 | 234 | 2013 |
| Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis S Watanabe, T Misu, I Miyazawa, I Nakashima, Y Shiga, K Fujihara, ... Multiple Sclerosis Journal 13 (8), 968-974, 2007 | 218 | 2007 |
| Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study Y Takai, T Misu, K Kaneko, N Chihara, K Narikawa, S Tsuchida, H Nishida, ... Brain 143 (5), 1431-1446, 2020 | 213 | 2020 |
Douglas Kazutoshi SatoPontifical Catholic University of Rio Grande do Sul在 pucrs.br 的电子邮件经过验证
